KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to -$860.2 million.

  • Aurinia Pharmaceuticals' Retained Earnings rose 829.82% to -$860.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$860.2 million, marking a year-over-year increase of 829.82%. This contributed to the annual value of -$936.6 million for FY2024, which is 61.04% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Retained Earnings stood at -$860.2 million for Q3 2025, which was up 829.82% from -$891.7 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Retained Earnings ranged from a high of -$625.5 million in Q1 2021 and a low of -$953.1 million during Q1 2024
  • Moreover, its 5-year median value for Retained Earnings was -$890.5 million (2023), whereas its average is -$852.5 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 2689.17% in 2022, then surged by 829.82% in 2025.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Retained Earnings stood at -$756.1 million in 2021, then dropped by 14.31% to -$864.3 million in 2022, then decreased by 9.03% to -$942.3 million in 2023, then increased by 0.61% to -$936.6 million in 2024, then grew by 8.16% to -$860.2 million in 2025.
  • Its Retained Earnings was -$860.2 million in Q3 2025, compared to -$891.7 million in Q2 2025 and -$913.2 million in Q1 2025.